OIC
BLUE

Orion Investment Company’s bluebird bio BLUE Stock Holding History

Orion Investment Company’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,288
Closed -$117K – 66
2024
Q3 		$117K Hold
11,288
– – 0.05% 66
2024
Q2 		$222K Buy
+11,288
New +$226K 0.09% 63

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Orion Investment Company's BLUE Position: Q4 2024 in Review

Orion Investment Company sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 11,288 shares — an estimated $117K sold.

Orion Investment Company first reported a position in BLUE in Q2 2024 and held it in 2 quarters. The position peaked at $222K in Q2 2024. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Orion Investment Company reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Orion Investment Company sold 11,288 bluebird bio shares in Q4 2024, an estimated $117K.
  • Orion Investment Company first reported a position in bluebird bio in Q2 2024 and held it in 2 quarters.
  • Orion Investment Company's bluebird bio position peaked at $222K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Orion Investment Company's 13F filing for Q4 2024, filed 13 Feb 2025.